date,title,source
Oct-17-18,Intersect ENT to Report Third Quarter 2018 Financial Results,Business Wire
Oct-25-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Intersect ENT, Akari Therapeutics, Ampio Pharmaceuticals, Virtusa, Umpqua, and Hamilton Lane  New Research Emphasizes Economic Growth",GlobeNewswire
Oct-29-18,Intersect ENT (XENT) Q3 Earnings Preview: What to Watch Ahead of the Release,Zacks
Oct-29-18,Intersect ENT Announces Executive Team Appointments,Business Wire
